EN DE

Johnson Health Tech .Co., Ltd (1736) Fair Value & Analysis

Consumer Cyclical · TW · Market cap 41.0B TWD

JH Johnson Health Tech .Co., Ltd 1736 · TW
Price137.00 TWD
Fair Value154.09 TWD
Upside+12.5%
Quality52/100
Watch Johnson Health Tech .Co., Ltd for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Thin margins · 4.5% net margin
Moderate debt · generates free cash flow
Ranks above peers (9/15)
Narrow moat 43/100
Evidence: High Range 75.18 TWD – 205.65 TWD Share as image

Fair value as of: Jul 21, 2026

From 26 valuation models · updated 20 days ago

Share price +3.8% over the past month.

A solid business, screening 12% undervalued on our models.

What matters now

  • The model range is unusually wide (75.18 TWD to 205.65 TWD). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • Our model range runs from 75.18 TWD (bear) to 205.65 TWD (bull), base 154.09 TWD. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 52/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

217.00 TWD 49.40 TWD Fair Value 154.09 TWD Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.

How to read this chart

60‑month range 49.40 TWD – 217.00 TWD · fair‑value band 75.18 TWD – 205.65 TWD · the 137.00 TWD price screens below the 154.09 TWD fair value. Dashed = 300-day average. As of Jul 21, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Johnson Health Tech .Co., Ltd (1736) currently trades at 137.00 TWD, while our model-based Fair Value estimate is 154.09 TWD, implying the stock looks roughly 12.5% undervalued today. The Quality Score stands at 52/100 (solid quality), in the Consumer Cyclical sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Johnson Health Tech .Co., Ltd generated revenue of 55.5B TWD at a net margin of 4.5%. Revenue grew 11.1% year over year. It earns a return on equity of 18.6%. Net debt stands at 16.1B TWD. Fundamentals as of Jul 21, 2026

Our scenario range runs from 75.18 TWD (bear case) to 205.65 TWD (bull case); at 137.00 TWD, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 29% below its 52-week high and 34% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at 2% fair-value upside, at 12%, 1736 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF 21.15 TWD 45.67 TWD 86.88 TWD 80
Residual Income 58.61 TWD 75.33 TWD 260.00 TWD 76
Rev-Margin DCF 70.49 TWD 144.36 TWD 238.68 TWD 74
All 26 models by family
DCF Models
FCF DCF 21.33 TWD 47.83 TWD 93.47 TWD 38
Owner Earnings 97.72 TWD 184.49 TWD 333.92 TWD 31
5Y Revenue Exit 70.49 TWD 147.67 TWD 254.48 TWD 39
5Y EBITDA Exit 95.31 TWD 198.46 TWD 329.44 TWD 41
5Y P/E Exit 91.76 TWD 191.18 TWD 305.74 TWD 38
10Y Revenue Exit 49.89 TWD 117.72 TWD 224.93 TWD 36
10Y EBITDA Exit 69.95 TWD 154.77 TWD 287.22 TWD 37
10Y P/E Exit 67.60 TWD 149.46 TWD 267.52 TWD 35
Earnings-Based
Graham-Dodd 61.64 TWD 278.47 TWD 381.84 TWD 54
Lynch FV 72.71 TWD 103.88 TWD 135.04 TWD 50
PEG = 1.0 72.71 TWD 103.88 TWD 135.04 TWD 46
EPV 63.46 TWD 76.07 TWD 87.12 TWD 59
Dividend Discount
Gordon GGM 36.73 TWD 76.36 TWD 121.14 TWD 70
DDM Multi-Stage 36.73 TWD 64.39 TWD 80.15 TWD 61
Multiples
P/E Multiple 149.56 TWD 199.42 TWD 249.27 TWD 63
P/S Multiple 115.57 TWD 154.09 TWD 192.62 TWD 58
P/B Multiple 115.57 TWD 154.09 TWD 192.62 TWD 55
EV/EBIT 147.57 TWD 200.84 TWD 254.11 TWD 53
EV/EBITDA 143.02 TWD 194.77 TWD 246.53 TWD 54
EV/Revenue 95.48 TWD 141.65 TWD 187.82 TWD 43
Asset-Based
NCAV (Graham) 22.63 TWD 30.32 TWD 45.25 TWD 50
Growth DCF
Growth DCF 21.15 TWD 45.67 TWD 86.88 TWD 80
Rev-Margin DCF 70.49 TWD 144.36 TWD 238.68 TWD 74
Economic Profit
Residual Income 58.61 TWD 75.33 TWD 260.00 TWD 76
ROIC Compounder 70.85 TWD 100.99 TWD 142.64 TWD 72
Growth Earnings
Growth-Adj P/E 120.99 TWD 172.84 TWD 224.69 TWD 68

Widest divergence: Growth Earnings (172.84 TWD) versus Asset-Based (30.32 TWD). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) 55.5B TWD
Revenue growth (YoY) +11.1%
Net margin 4.5%
Return on equity 18.6%
Free cash flow 798M TWD FY2025
P/E ratio 12.8
More key figures
Operating margin -0.8%
EPS (TTM) 9.06 TWD
EPS growth (YoY) -91.3%
Net debt 16.1B TWD FY2025

Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 52/100

Of which business quality 51 · Market factors (momentum, volatility) 43

Profitability 65
Margins and returns on capital today
Quality Growth 47
Are margins and returns improving?
Cashflow 20
Earnings quality: real cash, not paper profit
Fin. Strength 46
Balance sheet, leverage, solvency risk
Investment 61
Disciplined investing over empire-building
Low Volatility 67
Calm price path (market factor)
Momentum 34
Price trend over the last 3–12 months (market factor)
52W Momentum 29
Distance to the 52-week high (market factor)
Net Issuance 81
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Johnson Health Tech .Co., Ltd., together with its subsidiaries, manufacturers and sells fitness equipment in the Americas, Europe, Asia, and internationally.

Full company description

Johnson Health Tech .Co., Ltd., together with its subsidiaries, manufacturers and sells fitness equipment in the Americas, Europe, Asia, and internationally. The company offers cardiopulmonary resuscitation fitness machines, weight training machines, electric massage chairs and related motors, and instruments and electronic control panels, as well as instruments and electrical chairs, and related motors. It is also involved in buying and selling bodybuilding and weight training machines, and hearing aid; research and development, manufacturing, and sales of massage chair and sports equipment; provision of video streaming and transmission, and catering services; food wholesale; leasing business; and cultural communication activities. The company sells its products under the MATRIX, Vision Fitness, BowFlex, Schwinn, and Horizon brands. Johnson Health Tech .Co., Ltd. was incorporated in 1975 and is headquartered in Taichung, Taiwan.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Johnson Health Tech .Co., Ltd reported revenue of 54.3B TWD in FY2025 versus 30.8B TWD in FY2021, a compound +15.3%/yr. Reported net income was 2.8B TWD in FY2025, compounding +129.4%/yr from FY2021.

Growth Quality 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
54.3B TWD
Latest YoY
+13.7%
Avg. growth/yr (3Y)
+17.4%
Avg. growth/yr (5Y)
+13.9%
Avg. growth/yr (23Y)
+12.4%
Revenue +15.3%/yr
FY21 30.8B TWD
FY22 33.6B TWD
FY23 38.1B TWD
FY24 47.8B TWD
FY25 54.3B TWD
Net income +129.4%/yr
FY21 99.4M TWD
FY22 225M TWD
FY23 710M TWD
FY24 2.4B TWD
FY25 2.8B TWD

Watch 1736: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Johnson Health Tech .Co., Ltd Fair Value". https://www.fairvalue-calculator.com/stock/1736

Peer Group

Leisure · 192 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 52 · Below median
Fair Value upside +13% · Above median
Return on equity (TTM) 19% · Top 25%
Return on assets 5% · Above median
Net margin (TTM) 5% · Above median
Operating margin (TTM) -1% · Below median
Revenue growth 11% · Above median
Dividend yield (TTM) 0.0% · Bottom 25%
Debt / equity 0.51× · Higher than 75% of peers

Valuation Multiples vs Leisure median · lower = cheaper

P/E (TTM) 14.9× · Cheaper than median
P/B 2.98× · Pricier than median
P/S (TTM) 0.74× · Cheaper than median
P/FCF 1.6× · Cheaper than median
EV/EBITDA 11.0× · Pricier than median
PEG 0.57× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 50 · sector 14
FUTURE 56 · sector 18
PAST 74 · sector 19
HEALTH 74 · sector 94
DIVIDEND 0 · sector 51

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Leisure stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).

Stock Price Fair Value vs Fair Value
ANTA Sports Products Limited 2020 HK$74.15 HK$119.29 +61%
Pop Mart International Group 9992 HK$160.20 HK$227.30 +42%
Amer Sports, Inc AS $36.44 $16.16 -56%
Hasbro, Inc HAS $81.55 $83.38 +2%
Life Time Group LTH $42.15 $16.15 -62%
Acushnet Holdings GOLF $114.78 $37.79 -67%
Li Ning Company 2331 HK$14.80 HK$29.26 +98%
Benefit Systems S.A BFT 5,255 PLN 3,714 PLN -29%
Ninebot Limited 689009 ¥37.82 ¥39.17 +4%
Asmodee Group ASMDEEB kr 145.70 kr 41.90 -71%

Compare Johnson Health Tech .Co., Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Johnson Health Tech .Co., Ltd (1736) overvalued or undervalued?
As of Jul 21, 2026, our model estimates a fair value of 154.09 TWD versus a price of 137.00 TWD, about +12% (undervalued).
What is the fair value of 1736?
Our model-based fair value for Johnson Health Tech .Co., Ltd is 154.09 TWD (as of Jul 21, 2026), built from audited fundamentals. The current price is 137.00 TWD.
What is the quality score of 1736?
Johnson Health Tech .Co., Ltd has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Johnson Health Tech .Co., Ltd (1736)?
Johnson Health Tech .Co., Ltd reported trailing-twelve-month revenue of about 55.5B TWD (latest available figure, as of Jul 21, 2026).
What is the net profit margin of 1736?
The net profit margin of Johnson Health Tech .Co., Ltd is about 4.5%, meaning it keeps roughly 4.5% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Johnson Health Tech .Co., Ltd and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.